SARA DREW: Open Payments
NPI 1417262114 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 30 payments from 13 companies in 2025. Trend: 2023 $2,036 · 2024 $1,399 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 5 | $253 |
| MERZ NORTH AMERICA, INC. | 5 | $183 |
| Galderma Laboratories, L.P. | 2 | $122 |
| LEO Pharma Inc. | 1 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $87 |
| Incyte Corporation | 3 | $71 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $65 |
| ABBVIE INC. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Kerecis Limited | 1 | $34 |
Products named: DAXXIFY, Xeomin, NEMLUVIO, ANZUPGO, OPZELURA, Winlevi, BOTOX, Kerecis SurgiClose.
Industry payments across FL — which companies pay providers there.
